QQ客服 官方微博 反馈留言

	Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating beta-catenin
	Chen, Liping[1,2]; Mai, Weiqian[1,2]; Chen, Minfeng[1,2]; Hu, Jianyang[1,2]; Zhuo, Zhenjian[1,2]; Lei, Xueping[1,2]; Deng, Lijuan[1,2]; Liu, Junshan[3]; Yao, Nan[1,2]; Huang, Maohua[1,2]
	2017
卷号	123页码:130
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4291542
专题	暨南大学
作者单位	1.[1]Jinan Univ, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Guangdong, Peoples R China 3.[3]Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510632, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Chen, Liping[1,2],Mai, Weiqian[1,2],Chen, Minfeng[1,2],et al. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating beta-catenin[J],2017,123:130.
APA	Chen, Liping[1,2].,Mai, Weiqian[1,2].,Chen, Minfeng[1,2].,Hu, Jianyang[1,2].,Zhuo, Zhenjian[1,2].,...&Zhang, Dongmei[1,2].(2017).Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating beta-catenin.,123,130.
MLA	Chen, Liping[1,2],et al."Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating beta-catenin".123(2017):130.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。